DGX holder plans Rule 144 sale of 5,662 shares

A holder of DGX common stock has filed a notice of intent to sell 5,662 shares under Rule 144.

Rhea-AI Filing Summary

A holder of DGX common stock has filed a notice of intent to sell 5,662 shares under Rule 144. The planned sale, through Fidelity Brokerage Services LLC on the NYSE, has an stated aggregate market value of $1,155,048.00.

The shares are part of DGX common stock, with 111,242,362 shares outstanding at the time referenced. The seller acquired these 5,662 shares on 02/10/2026 by exercising a stock option originally granted on 02/17/2021, and paid the purchase price in cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DGX shares are planned for sale under this Rule 144 notice?

The notice covers a planned sale of 5,662 DGX common shares. These shares were acquired through an option exercise and will be sold through a broker on a national exchange, subject to Rule 144 conditions.

What is the aggregate market value of the DGX shares to be sold?

The planned sale has an aggregate market value of $1,155,048.00. This figure reflects the total market value of the 5,662 DGX common shares covered by the notice at the time the information was provided.

When were the DGX shares being sold under Rule 144 acquired?

The 5,662 DGX common shares were acquired on 02/10/2026. They came from exercising a stock option that was originally granted on 02/17/2021, with the purchase price paid in cash at the time of exercise.

What was the nature of the transaction used to acquire the DGX shares?

The shares were obtained via an option granted on 02/17/2021, which was exercised on 02/10/2026. The holder paid cash for 5,662 DGX common shares as part of this option exercise transaction.

Which broker and exchange are involved in this DGX Rule 144 sale?

The planned Rule 144 sale will use Fidelity Brokerage Services LLC as broker. The 5,662 DGX common shares are expected to be sold on the New York Stock Exchange (NYSE), according to the information provided.

How many DGX common shares were outstanding when this sale was planned?

The filing lists 111,242,362 DGX common shares outstanding. This figure provides context for the relative size of the planned 5,662-share sale described under Rule 144 in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 12:46 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001497368
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QUEST DIAGNOSTICS INC
SEC File Number	001-12215
Address of Issuer	500 PLAZA DRIVE SECAUCUS NEW JERSEY 07094
Phone	9735202700
Name of Person for Whose Account the Securities are To Be Sold	Plewman Patrick
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5662	1155048.00	111242362	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Option Granted - 02/17/2021	Issuer			5662	02/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Patrick Plewman and Thomas P. Plewman are one and the same person.
Date of Notice	02/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas P. Plewman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)